Microbial DNA | Stool Profile
GI-MAP Microbiome Mapping
GI-MAP Microbiome Mapping
The gastrointestinal microbial environment can be explored using molecular stool testing when the results are likely to add useful clinical context. GI-MAP Microbiome Mapping at Yoyime Wellness Clinic in Dubai uses a specialised stool assay based on quantitative PCR technology to report selected bacterial, parasitic and viral organisms, H. pylori and other microbial targets included within the chosen panel. Our clinician reviews results alongside symptoms and conventional investigations, using microbial findings as supplementary information rather than treating a microbiome profile as a standalone diagnosis.
Benefits of GI-MAP Microbiome Mapping
Provides Microbial DNA Profile
Identifies Selected Microbial Targets
Supports Focused Clinical Review
Recommended for Patients With
Clinician Selected Microbial Investigation
Complex Gastrointestinal Symptoms
Previous Gastrointestinal Infection Concerns
Step-By-Step Procedure - GI-MAP Microbiome Mapping
Clinical Consultation
Our clinician establishes why molecular gastrointestinal testing is being considered.
Suitability Review
Symptoms, previous investigations, medicines and gastrointestinal history are assessed.
Test Selection
GI-MAP is selected only when its microbial information may contribute to assessment.
Collection Guidance
Detailed stool sample collection and handling instructions are provided.
Sample Collection
The stool specimen is collected and submitted according to laboratory requirements.
Molecular Analysis
The laboratory measures selected microbial DNA targets using quantitative PCR methodology.
Clinical Interpretation
Results are reviewed alongside symptoms and other validated diagnostic findings.
Follow Up Direction
Confirmatory testing, treatment or specialist review is considered when clinically appropriate.
Have questions about GI-MAP Microbiome Mapping?
Message our team on WhatsApp for personalised guidance before you book.
- Profile selected gastrointestinal microbes using specialised quantitative PCR stool analysis technology.
- Interpret microbial findings cautiously alongside symptoms, history and conventional clinical testing.
Frequently Asked Questions
GI-MAP Microbiome Mapping
Yoyime's GI-MAP service uses a specialised quantitative PCR stool assay to analyse DNA from selected gastrointestinal microbial targets within the test panel.
The manufacturer's panel includes selected bacterial, viral and parasitic pathogens, H. pylori, selected commensal and opportunistic organisms and additional gastrointestinal markers depending on the panel ordered.
Quantitative PCR is a molecular laboratory technique used to detect and measure specific DNA targets within a sample.
No. GI-MAP is positioned at Yoyime as the microbial DNA profiling service. Comprehensive Stool Analysis is positioned around digestive function, intestinal inflammation and clinically selected conventional stool markers.
No. A microbial stool profile does not independently diagnose conditions such as IBS, inflammatory bowel disease, SIBO or food intolerance. Results require clinical interpretation and appropriate conventional testing.
No. International expert consensus notes that interest in microbiome diagnostics is high but evidence supporting broad clinical usefulness remains limited. This is why Yoyime uses results within the wider clinical picture.
No. Stool microbial testing is not the same as assessment of the small intestine. Suspected SIBO is handled through the dedicated SIBO Breath Test pathway.
No. Our clinician considers organism type, quantity, symptoms, clinical significance and other findings before recommending further testing or treatment.
Recent antibiotics, antimicrobial treatments and other medicines may affect gastrointestinal microbial findings. Preparation instructions should therefore be followed carefully.
Cost depends on the GI-MAP panel selected and consultation requirements. At Yoyime, our team explains the test scope and associated costs before ordering.
